Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Participants

PHASE3CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

April 20, 2011

Primary Completion Date

October 25, 2012

Study Completion Date

October 25, 2012

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

Imatinib

Film coated tablets, oral administration

DRUG

Sildenafil

Oral Administration

DRUG

Bosentan

Oral Administration

Trial Locations (11)

1070

Novartis Investigative Site, Brussels

2010

Novartis Investigative Site, Darlinghurst

3000

Novartis Investigative Site, Leuven

11501

Novartis Investigative Site, Mineola

12683

Novartis Investigative Site, Berlin

30625

Novartis Investigative Site, Hanover

33331

Novartis Investigative Site, Weston

33606

Novartis Investigative Site, Tampa

00161

Novartis Investigative Site, Roma

LT-08661

Novartis Investigative Site, Vilnius

NW3 2PR

Novartis Investigative Site, London

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY